Key Takeaways
- Volume-led quarter, margin squeeze: Sales volumes rose on proactive DAP and P&K procurement, but high international input prices compressed margins and drove up working capital debt.
- Crop protection delivered standout growth: The segment grew 64%, with volume contributing more than two-thirds of that expansion, as geographic reach and channel strategy paid off.
- Debt is episodic, not structural: The spike in borrowings reflects commodity price inflation flowing through subsidy receivables; management expects it to cycle out within two to three quarters.
- Nano urea is being watched, not feared: Management is running its own trials and sees no threat to conventional urea demand in the coming years, calling the evidence so far early and inconclusive.
- What to watch next quarter: Whether softening international P&K prices actually lift DAP margins, the pace at which subsidy-linked working capital debt begins to unwind, and any update on the ammonium nitrate project’s commercial discussions.
Crop Protection & Specialty Nutrients
- Growth engine firing: The segment posted another quarter of double-digit growth, with the 64% expansion driven significantly by volume (more than two-thirds) rather than price increases alone.
- Geographic push gaining traction: Expansion beyond core regions, begun last year, is now generating sales in new territories for both crop protection and specialty nutrients despite two tumultuous years in the global fertiliser industry.
- Three-year ambition: Management is targeting growth to approximately 3x of the last financial year’s base over the next 3–4 years.
- Competitive differentiation: Management points to a strong brand and faster decision-making speed in the market as advantages over cooperative players.
Gaurav Mathur: “The second thing, you know, which differentiates Chambal from your mentioned cooperative players, is that we have a very strong brand, right, one. Second, our decision making processes, our speed in the market, all of those are significantly, I would say, different from if you would take cooperatives.”
Margin & Input Price Dynamics
- The ratio story: 90% of the margin ratio decline is a numerator/denominator effect: turnover surged to ₹7,200 Crores on sharp price increases while EBITDA and PAT stayed roughly flat. Traded product margins did decline, but that is not the major driver of the ratio drop.
- DAP margins under pressure: Substantial decline in DAP margin came from high input prices and prevailing market conditions. International market prices have peaked and started softening over the last two to three weeks, but the situation remains dynamic.
- Input cost relief emerging: Sulphur prices have fallen substantially; ammonia has declined but is steady and needs monitoring. Management expects an overall softening trend in international prices going forward.
- Inventory gain negligible: The inventory gain component in EBITDA was almost nil for the quarter.
- DAP strategy is deliberate, not defensive: The company takes a logical view of the situation, weighing government subsidy stance, industry margins, and food-security supply needs, rather than chasing market share for its own sake.
Gaurav Mathur: “We are not necessarily focused just to maintain market share for the sake of maintaining market share. So, we take a logical view of the situation. We also look at what Government stance is in terms of subsidy, in terms of how they see the industry with the margins and so on and take decisions based on these number of factors.”
Debt & Working Capital
- Episodic by nature: The debt build-up is tied to subsidy receivables, inflated this year purely by commodity price inflation flowing through the system. Long-term debt continues to be paid on schedule.
- Cycling out soon: The high-price-inflation entry is expected to cycle out within two to three quarters as subsidy gets fixed. The debt-equity ratio, which moved above one this year on the same inflation dynamic, should normalise on the same timeline.
- Subsidy-linked portion to ease by year-end: Additional working capital debt driven by high subsidy (a function of high prices and a higher subsidy-to-market-realisation ratio) is expected to start coming down by the end of the year, supported by government talk of supplementary budget allocations.
Abhay Baijal: “Actually Faisal, point is that the debt is episodic, coming out of subsidy build-up and repayment and so on.”
Urea Operations & Energy
- Steady production: Urea production and sales volumes showed little variation versus the corresponding quarter last year.
- Energy efficiency adding to the bottom line: Schemes implemented in both Gadepan-I and Gadepan-II plants contributed positively.
- Gas supply intact: Despite news of a 10% cut, plants continue to operate at full capacity. The company has tied up with spot gas and does not foresee disruption in the coming months.
- Shutdown cycle complete: Gadepan II shut down in February 2022, Gadepan I in March–April 2022. Both are done; next shutdowns are due in March 2024. Only Gadepan III will have its bi-annual shutdown, due in March 2023.
- No further capacity addition needed: Management sees total urea capacity after new plants coming very close to the country’s total requirement, so further additions are not warranted at this point.
Nano Urea & Demand Risks
- Early days, own trials underway: The company is monitoring nano urea application closely and conducting its own trials. Management stresses that the overall impact on total urea consumption must be assessed across multiple seasons and multiple crops.
- No threat seen to conventional urea: Public statements from various sources do not indicate nano urea will substantially replace conventional urea, and management sees no threat to its urea business in the coming years.
- An Indian innovation story: Nano urea has not been tried anywhere else in the world; management frames its Indian introduction as part of the country’s current innovation push.
Gaurav Mathur: “So, this nano urea has not been tried anywhere else in the world. Why it is being tried in India? Well, it's an innovation, right? So, if innovation, as you know, there is a big thrust in India on innovation nowadays. So, it probably is a part of that.”
Projects & Strategic Initiatives
- Ammonium Nitrate project on track: The project is progressing as planned, with commercial discussions ongoing with international vendors of repute and the statutory approval process moving forward.
- Seed-to-harvest program expanding: The pilot has progressed well, addressing key kharif crops including paddy, cotton, maize, oil seeds, and vegetables. The program will continue through Rabi and widen its geographical scope. Economics are better than breakeven at the EBITDA level.
- IMACID shutdown completed: The annual 30–35 day shutdown (once every two years) was carried out during the quarter. Management expects a return to normal production in the next two or three quarters; structurally, the JV continues to work as a hedge with Chambal’s one-third participation in the value chain. No immediate capacity expansion is planned.
- Morocco and acquisition options: The company keeps evaluating investment opportunities in Morocco and actively looks at all options for sourcing product, including whether to continue with a trading model or install its own plant. Management declined to comment on specific acquisition evaluations.
- Industry inventory visibility lost: The government’s Fertiliser Monitoring System (FMS), which previously allowed companies to see industry-wide inventory data, is no longer visible to any company.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Crop protection growth | Grow to approximately 3x of last financial year’s base | Next 3–4 years |
| Working capital debt normalisation | High-price-inflation-driven debt to cycle out as subsidy gets fixed | Within 2–3 quarters |
| Subsidy-linked debt reduction | Additional working capital debt from high subsidy to start coming down | By end of year, contingent on supplementary budget allocations |
| IMACID production recovery | Return to normal production levels | Next 2–3 quarters |
| Gadepan III shutdown | Bi-annual shutdown | March 2023 |
| Gadepan I & II next shutdowns | Next scheduled shutdowns | March 2024 |
| Seed-to-harvest program | Continue through Rabi and widen geographical scope | Ongoing through Rabi season |
Key Metrics
| Metric | Q1 FY23 |
|---|---|
| Turnover | ₹7,200 cr |
| EBITDA | Maintained, more or less the same as previous comparable period |
| PAT (standalone) | Maintained, more or less the same as previous comparable period |
| Crop protection and specialty nutrients revenue growth | 64%, more than two-thirds volume-driven |
| Crop protection business growth target | 3x of FY22 base over the next 3–4 years |
| Urea production capacity utilization | 115–120% of re-assessed capacity for Gadepan-I and II, full capacity for Gadepan-III |
| Gadepan-III sales volume | 3.5 lakh metric tons |
| DAP volume rise | 1.05 lakh metric tons |
| Energy price (gas) | USD 24 per MMBTU net calorific value |
| Gas sourcing mix | 80% long-term contracts, 15–20% spot |
| Subsidy debtors | ₹5,485 cr, urea ₹3,400 cr and P&K ₹1,300 cr |
| Interest rate on excess working capital debt | About 5.5% |
| Long-term debt repayment | Almost USD 100 million a year |
| IMACID capacity | Close to 5 lakh tons |
| IMACID shutdown duration | 30–35 days annual shutdown, once in two years |